EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis

Joanna A Vuille, Cem Tanriover iD, Ezgi Antmen iD, Douglas S Micalizzi, Richard Y Ebright iD, Sambhavi Animesh, Robert Morris, Soroush Hajizadeh, Zachary J Nicholson, Hunter C Russell, Eric F Zaniewski, Ben S Wittner und 13 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2425621122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Joanna A Vuille und 24 weiteren Autor:innen. Beteiligte Einrichtung: Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Cyclooxygenase 2, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, HHS | NIH | Center for Scientific Review (CSR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

E3 ubiquitin ligases mediating turnover of proteins engaged in cancer progression point to key regulatory nodes. To uncover modifiers of metastatic competency, we conducted an in vivo genome-wide CRISPR-inactivation screen using cultured breast circulating tumor cells, following intravascular seeding and lung colonization. We identified HECTD4, a previously uncharacterized gene encoding a conserved potential homologous to E6AP C-terminus domain–containing ubiquitin transferase, as a potent tumor and metastasis suppressor. We show that purified HECTD4 mediates ubiquitin conjugation in vitro, and proteomic studies combined with ubiquitin remnant profiling identify a major degradation target as the prostaglandin synthetic enzyme cyclooxygenase-2 ( COX-2 ; PTGS2 ). In addition to COX-2 itself, HECTD4 targets its regulatory kinase MKK7. In breast cancer models, HECTD4 expression is induced as cells lose adherence to the matrix, and its depletion massively increases COX-2 expression, enhancing anchorage-independent proliferation and tumorigenesis. Genetic or pharmacologic suppression of COX-2 reverses the protumorigenic and prometastatic phenotype of HECTD4-depleted cells. Thus, HECTD4 encodes an E3 ubiquitin ligase that downregulates COX-2 suppressing anchorage independence in epithelial cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesCyclooxygenase 2Breast NeoplasmsHumansAnimalsNeoplasm MetastasisFemaleMiceCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticUbiquitinationCell Proliferation

Stichwörter der Autor:innen

anchorage independencebreast cancermetastasis suppressor genestumor suppressor geneubiquitination

Substanzen

Ubiquitin-Protein LigasesCyclooxygenase 2PTGS2 protein, human

Autor:innen und Institutionen

  • Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129.
  • Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne 1005, Switzerland.
  • Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, MA 02129.
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02115.
  • HHMI, Chevy Chase, MD 20815.
  • Arena BioWorks, Cambridge, MA 02142.

ORCID-Profile: Cem Tanriover, Ezgi Antmen, Richard Y Ebright, Daniel A Haber

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • HHS | NIH | Center for Scientific Review (CSR)
  • NIBIB NIH HHS
  • Breast Cancer Research Foundation (BCRF)
  • Placide Nicod Foundation
  • National Foundation for Cancer Research (NFCR)
  • ESSCO Breast Cancer Research Fund

Zitieren

APA

Vuille, J. A., Tanriover, C., Antmen, E., Micalizzi, D. S., Ebright, R. Y., Animesh, S., Morris, R., Hajizadeh, S., Nicholson, Z. J., Russell, H. C., Zaniewski, E. F., Wittner, B. S., Wesley, B. K., Kwak, J. E., Grünewald, J., Szalay, R. N., Fox, D. B., Yang, M., Joung, J. K., …, & Haber, D. A. (2025). The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2425621122

Vancouver

Vuille JA, Tanriover C, Antmen E, Micalizzi DS, Ebright RY, Animesh S, et al. The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2425621122

BibTeX
@article{Vuille2025,
  author = {Vuille, Joanna A and Tanriover, Cem and Antmen, Ezgi and Micalizzi, Douglas S and Ebright, Richard Y and Animesh, Sambhavi and Morris, Robert and Hajizadeh, Soroush and Nicholson, Zachary J and Russell, Hunter C and Zaniewski, Eric F and Wittner, Ben S and Wesley, Ben K and Kwak, Ji Eun and Grünewald, Julian and Szalay, Regan N and Fox, Douglas B and Yang, Min and Joung, J Keith and Gulhan, Doga C and Elia, Andrew E H and Haas, Wilhelm and Oh, Eugene and Maheswaran, Shyamala and Haber, Daniel A},
  title = {The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2425621122}
}
Kostenlos starten →